MSI/MMR | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

8,453 results for “MSI/MMR”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

MMR/MSI Phenotypes in Prediction of Tumor Vaccine Benefit for Gliomas

360 participants · First posted Sep 21, 2023

Active, not recruiting

Atezolizumab in Patients With MSI-h/MMR-D Stage II High Risk and Stage III Colorectal Cancer Ineligible for Oxaliplatin

80 participants · First posted Nov 12, 2021

Niraparib and Dostarlimab for Patients with MMR-D/MSI-H Colorectal Cancers

20 participants · First posted Apr 15, 2024

A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR/MSI Status

174 participants · First posted Dec 30, 2022

Active, not recruiting

iRECIST Evaluation's Relevance for DCR in MMR/MSI Metastatic Colorectal Cancer Patients on Nivolumab and Ipilimumab

57 participants · First posted Nov 22, 2017

Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery

62 participants · First posted Mar 1, 2021

Not yet recruiting

Clinical Trial to Assess the Efficacy of Dostarlimab as Neoadjuvant Therapy in Patients With MMRd/MSI-H Stage II-III Endometrial Cancer

25 participants · First posted Jun 10, 2025

A Retrospective Validations Microsatellite Instability (MSI) Testing v Mismatch Repair (MMR) in Gastric Adenocarcinoma

50 participants · First posted Jan 18, 2020

Safety and Tolerability of MSI-1436C in Metastatic Breast Cancer

5 participants · First posted Aug 17, 2015

A Single Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic Volunteers

28 participants · First posted Feb 1, 2008

Page 1 of 691